PMID: 9188842Feb 1, 1997Paper

Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc

Molecular Immunology
A S Thøger AndersenS Junker

Abstract

Regulation of immunoglobulin heavy chain (IgH) gene expression is controlled by a B cell-specific promoter, intronic enhancer and additional B cell-specific enhancer elements identified recently in the 3' end of the IgH locus. One of the latter elements, the IgH 3' enhancer, is of particular interest: (1) it is B cell-specific and active only in late B cell development; (2) in rodent plasmacytomas and in some human Burkitt's lymphomas it is part of a locus control region (LCR) that is involved in deregulation of the c-myc oncogene as a result of translocation into the IgH locus; and (3) it has been implicated in the mechanisms that control Ig gene class switch recombination. We have used a somatic cell hybridization approach to genetically analyse regulation of the activity of the IgH 3' enhancer. When mouse MPC11 plasmacytoma cells, in which the IgH 3' enhancer is active, are fused with fibroblasts, Ig expression is extinguished at the level of transcription. Here we show that in a MPC11 plasmacytoma x fibroblast environment, the IgH 3' enhancer is transcriptionally inactive. Furthermore, we demonstrate that binding of several B cell-specific transcription factors, essential for IgH 3' enhancer activity, is lacking, which may ...Continue Reading

References

Nov 1, 1978·Somatic Cell Genetics·D Schall, M Rechsteiner
Dec 1, 1991·Current Opinion in Cell Biology·H D Lipshitz
Jun 1, 1991·European Journal of Immunology·P DariavachM S Neuberger
Jan 1, 1991·Annual Review of Immunology·L M Staudt, M J Lenardo
Jan 11, 1991·Nucleic Acids Research·T WirthB Oeler
Jan 1, 1990·Annual Review of Cell Biology·H Gourdeau, R E Fournier
Mar 15, 1990·International Journal of Cancer. Journal International Du Cancer·T OikawaN Kuzumaki
Jan 1, 1989·Experimental Cell Research·S JunkerD Picard
Jan 15, 1989·International Journal of Cancer. Journal International Du Cancer·A GreenbergR Laskov
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·T OikawaN Kuzumaki
Oct 15, 1981·Biochemical and Biophysical Research Communications·S Junker, S Pedersen
Jan 26, 1995·Nature·M GstaigerC M Hovens
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·V J RobertsC Murre
Jan 15, 1993·European Journal of Biochemistry·B WasylykA Giovane
Dec 1, 1995·Molecular Immunology·V ArulampalamS Pettersson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.